PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IEP vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IEP and JNJ is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

IEP vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Icahn Enterprises L.P. (IEP) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%AugustSeptemberOctoberNovemberDecember2025
608.57%
4,583.53%
IEP
JNJ

Key characteristics

Sharpe Ratio

IEP:

-0.81

JNJ:

-0.35

Sortino Ratio

IEP:

-1.01

JNJ:

-0.41

Omega Ratio

IEP:

0.86

JNJ:

0.95

Calmar Ratio

IEP:

-0.47

JNJ:

-0.31

Martin Ratio

IEP:

-1.46

JNJ:

-0.79

Ulcer Index

IEP:

24.35%

JNJ:

6.88%

Daily Std Dev

IEP:

43.98%

JNJ:

15.48%

Max Drawdown

IEP:

-84.21%

JNJ:

-52.60%

Current Drawdown

IEP:

-74.38%

JNJ:

-14.32%

Fundamentals

Market Cap

IEP:

$4.76B

JNJ:

$353.99B

EPS

IEP:

-$1.02

JNJ:

$6.04

PEG Ratio

IEP:

0.00

JNJ:

0.86

Total Revenue (TTM)

IEP:

$7.10B

JNJ:

$66.30B

Gross Profit (TTM)

IEP:

$385.00M

JNJ:

$45.96B

EBITDA (TTM)

IEP:

$113.00M

JNJ:

$22.61B

Returns By Period

In the year-to-date period, IEP achieves a 8.19% return, which is significantly higher than JNJ's 1.67% return. Over the past 10 years, IEP has underperformed JNJ with an annualized return of -9.32%, while JNJ has yielded a comparatively higher 6.72% annualized return.


IEP

YTD

8.19%

1M

0.97%

6M

-39.63%

1Y

-33.89%

5Y*

-19.72%

10Y*

-9.32%

JNJ

YTD

1.67%

1M

1.58%

6M

-3.46%

1Y

-5.91%

5Y*

2.52%

10Y*

6.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IEP vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IEP
The Risk-Adjusted Performance Rank of IEP is 1010
Overall Rank
The Sharpe Ratio Rank of IEP is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of IEP is 1010
Sortino Ratio Rank
The Omega Ratio Rank of IEP is 1010
Omega Ratio Rank
The Calmar Ratio Rank of IEP is 1818
Calmar Ratio Rank
The Martin Ratio Rank of IEP is 66
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2626
Overall Rank
The Sharpe Ratio Rank of JNJ is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 2222
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 2323
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2828
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IEP vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Icahn Enterprises L.P. (IEP) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IEP, currently valued at -0.81, compared to the broader market-2.000.002.004.00-0.81-0.35
The chart of Sortino ratio for IEP, currently valued at -1.01, compared to the broader market-4.00-2.000.002.004.00-1.01-0.41
The chart of Omega ratio for IEP, currently valued at 0.86, compared to the broader market0.501.001.502.000.860.95
The chart of Calmar ratio for IEP, currently valued at -0.47, compared to the broader market0.002.004.006.00-0.47-0.31
The chart of Martin ratio for IEP, currently valued at -1.46, compared to the broader market-10.000.0010.0020.0030.00-1.46-0.79
IEP
JNJ

The current IEP Sharpe Ratio is -0.81, which is lower than the JNJ Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of IEP and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.81
-0.35
IEP
JNJ

Dividends

IEP vs. JNJ - Dividend Comparison

IEP's dividend yield for the trailing twelve months is around 37.31%, more than JNJ's 3.34% yield.


TTM20242023202220212020201920182017201620152014
IEP
Icahn Enterprises L.P.
37.31%40.37%34.90%15.79%16.13%15.79%13.01%12.26%11.32%10.01%9.79%6.49%
JNJ
Johnson & Johnson
3.34%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

IEP vs. JNJ - Drawdown Comparison

The maximum IEP drawdown since its inception was -84.21%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for IEP and JNJ. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-74.38%
-14.32%
IEP
JNJ

Volatility

IEP vs. JNJ - Volatility Comparison

Icahn Enterprises L.P. (IEP) has a higher volatility of 10.21% compared to Johnson & Johnson (JNJ) at 5.21%. This indicates that IEP's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
10.21%
5.21%
IEP
JNJ

Financials

IEP vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Icahn Enterprises L.P. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab